🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
43Score
DipBuster Score™
$24.74
+$0.195 (+0.79%)
Live price · Source: Yahoo
52-Week Position
$23.11
29% of range
$28.75
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$28.75
52W Low$23.11
DipBuster Brief
Key signals at a glance
Zone: Buy Zone
Neutral
Mid-Range Position (29% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position29% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Pfizer Inc. (PFE), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-07-15 | Bourla Albert | BUY | 24 |
| 2026-07-09 | Bourla Albert | BUY | 84 |
| 2026-06-30 | Bourla Albert | BUY | 25 |
| 2026-06-15 | Bourla Albert | BUY | 23 |
| 2026-06-09 | Damico Jennifer B. | SELL | 2,000 |
| 2026-05-29 | Bourla Albert | BUY | 23 |
| 2026-05-15 | Bourla Albert | BUY | 24 |
| 2026-04-30 | Bourla Albert | BUY | 22 |
| 2026-04-23 | Buckley Mortimer J | BUY | 7,687 |
| 2026-04-23 | Littman Dan R. | BUY | 7,687 |
Valuation
P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$28.75
52W Low$23.11
52-Week Range
$23.11Now$28.75
29% through annual range
From 52W High−14%
From 52W Low+7%
📖 Plain English Summary
Pfizer Inc. is at 29% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for PFE
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — PFE
Heuristic · balance sheet, insider filings, price data, academic research
Pfizer Inc. — DipBuster Score 43/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Pfizer Inc. free
Add PFE to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
28/25
Momentum & Volume
10/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
21
/100 · NEUTRAL
dip depth
19/25
oversold rsi
2/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 43/100
📊
Run a full check in the AI analysis tab for a deeper look.